SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011616
Filing Date
2018-08-14
Accepted
2018-08-14 08:02:06
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 405138
2 ex31-1.htm EX-31.1 18773
3 ex31-2.htm EX-31.2 17921
4 ex32-1.htm EX-32.1 7532
5 ex32-2.htm EX-32.2 7339
  Complete submission text file 0001493152-18-011616.txt   2607432

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aitb-20180630.xml EX-101.INS 387421
7 XBRL SCHEMA FILE aitb-20180630.xsd EX-101.SCH 32043
8 XBRL CALCULATION FILE aitb-20180630_cal.xml EX-101.CAL 42837
9 XBRL DEFINITION FILE aitb-20180630_def.xml EX-101.DEF 140568
10 XBRL LABEL FILE aitb-20180630_lab.xml EX-101.LAB 249773
11 XBRL PRESENTATION FILE aitb-20180630_pre.xml EX-101.PRE 199869
Mailing Address 825 EAST GATE BOULEVARD, SUITE 320 GARDEN CITY NY 11530
Business Address 825 EAST GATE BOULEVARD, SUITE 320 GARDEN CITY NY 11530 516-665-8200
AIT Therapeutics, Inc. (Filer) CIK: 0001641631 (see all company filings)

IRS No.: 473812456 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55759 | Film No.: 181014356
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10